During trading today, both the Health Care sector (XLV) and the S&P500 showed little movement.

As a proxy for the sector, the ETF tracked closer to the overall market today than over the past month. As trading began today, XLV was up 3.7% over the last thirty trading days, and the S&P 500 climbed 2.1%.

Stereotaxis (STXS) rose 1063.7% to close at $1.99, cross its 50-day moving average of 25 cents and 200-day moving average of 53 cents. Mednax (MD) declined 1.3% to close at $66.75, moving below its 50-day moving average of $64.69 and 200-day moving average of $68.32.

Genomic Health (THOR) fell 3% to close at $34.65, moving closer to its 50-day moving average of $33.95. Also, the stock moved closer to its 200-day moving average of $32.58.

Pharmacyclics (PCYC) was a major loser in the sector, falling 7.8% (-$4.46) to close at $52.87 with 3.1 million shares moving. The stock traded between $50.27 and $58.52.

Rochester Medical Corporation (ROCM) was a significant gainer in the sector, rising 4.7%. The stock closed at $11.62 with 52,630 shares moving. The stock traded in a range of $11.07 to $11.81. Shares have been on on the rise over the past three months, climbing $1.16 (11.1%) from a price of $10.46 on June 11, 2012.